H1 2024 Life Sciences Update Market Summaries

Germany: Rhine-Neckar Region

View H1 2024 Life Sciences Update

View All Markets

Market Summary

Public & Private Funding (2023/24)

Fast Lab Stats

• The recent changes in the financing environment shook the German real estate market in 2023, but the first half of 2024 shows a stabilization in yields. • The Rhine-Neckar region, particularly Mainz and Heidelberg, has experienced a significant rise in interest from public institutions seeking to increase exposure to the life sciences sector. Existing life sciences campuses will be expanded and receive public funding for growth. The region is emerging as an interregional cluster with life sciences campuses. • The region boasts a prestigious university landscape, including university hospitals in Heidelberg and Mannheim, as well as several key institutions, such as the German Cancer Research Centre, the European Molecular Biology Laboratory and the Max Planck Institute. • Health + Life Sciences Alliance Heidelberg Mannheim, an innovative network of university institutions and research centers, has been established to strengthen the sector within the economic region and to expand it into a leading international cluster in the life sciences. • There are 12 life sciences companies employing more than 10,000 people in Mainz, Heidelberg, Mannheim and Ludwigshafen.

€ Raised (MM)

Company

Deal Type

Completed

Type

150K Total Life Sciences Employment > 64 Life Science Companies > 10 Research facilities/ institutes

NeraCare

Later Stage VC

May 2024

1st Round

€ 21.6

FundaMental Pharma

Seed Round

Apr 2024

1st Round

€ 13.8

FaCellitate

Accelerator/Incubator

Apr 2024

AaviGen

Early Stage

Jul 2023

VC

€ 17.0

Genome Biologics

Later Stage

Jan 2023

VC

WMT

Early Stage

Nov 2023

VC

Representative Investment Sale Transactions (Q3 2022 – Q2 2024)

Address

Type

Volume (€m) Confidential

GLA (sqm)

Date Buyer

Honeycamp Building, Mannheim R&D / Office

11,500 2022 Q4 BNP Paribas REIM

Representative Life Sciences Companies

Life Sciences Labor: Annual Chemist Job Postings

Company

Type

100 150 200 250 300 350 400 450

Representative Lease Transactions (Q3 2022 – Q2 2024)

Company

Address

GLA (sqm) New/Renewal

Type

Quarter

Landlord

Cellzome

Biotechnology

Ascendis Pharma

Grüne Meile, Heidelberg

11,650 New letting

Office/labs

Q3 2022

Max-Jarecki-Stiftung

BD Becton Dickinson Anwerina Deutschland

Medtech

AbbVie Pharmaceutics Knollstraße 50

8,000 Owner Occupier

Office

Q1 2024

AbbVie Pharmaceutics

Pharma

Reckit Beckister

Chemicals

- 50

Roche Diagnostics

Pharma

2019

2020

2021

2022

Bio Degree-Awarding Institutions, Metro Area • Heidelberg University • Ruprecht-Karls-Universität Heidelberg • Johannes Gutenberg-Universität Mainz • Hochschule Mannheim • Karlsruhe Institute of Technology (KIT)

Contributors Benedikt Kiefer benedikt.kiefer@cushwake.com

Simon Jeschioro simon.jeschioro@cushwake.com

Sources: Cushman & Wakefield Research, CoStar, National Institutes of Health (NIH), Lightcast, Pitchbook, Federal Reserve Economic Data (FRED)

CUSHMAN & WAKEFIELD

LIFE SCIENCES UPDATE | 2024 SEPTEMBER

Made with FlippingBook - Online magazine maker